Top-tier investor syndicate led by FoundersX Ventures, with participation from all existing investors and new investors Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and ...
Spectris increased CSF levels of multiple HDL-like lipid transport proteins, suggesting a “coordinated biological response” ...
Hosted on MSN
A light-and-sound headset for Alzheimer’s is finishing a major late-stage trial this month
Cognito Therapeutics is wrapping up the largest clinical trial ever conducted on a non-drug device for Alzheimer’s disease. The HOPE study, a randomized, double-blind, sham-controlled trial of the ...
Alzheimer’s disease serves as bookends to Brent Vaughan’s career so far. Twenty years ago, he worked for a Bay Area biotech whose pipeline included small molecules in development for the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results